SGLT2is has multifaceted mechanisms of action for the treatments of AD, such as encompassing antioxidative stress, anti-neuroinflammation, the upregulation of autophagy, anti-apoptosis, the protection of endothelial cells, and acetylcholinesterase (AChE) inhibitor activity [207]. This evidence concerns the gene ACHE and Alzheimer disease.